These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3992620)

  • 1. Simultaneous plasma carbamazepine and carbamazepine-epoxide concentrations in pharmacokinetic and bioavailability studies.
    Hooper WD; King AR; Patterson M; Dickinson RG; Eadie MJ
    Ther Drug Monit; 1985; 7(1):36-40. PubMed ID: 3992620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of carbamazepine and carbamazepine-epoxide, determined by use of plasma and saliva.
    Westenberg HG; van der Kleijn E; Oei TT; de Zeeuw RA
    Clin Pharmacol Ther; 1978 Mar; 23(3):320-8. PubMed ID: 627139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous liquid chromatographic analysis for carbamazepine and carbamazepine 10,11-epoxide in plasma and saliva by use of double internal standardization.
    MacKichan JJ
    J Chromatogr; 1980 Mar; 181(3-4):373-83. PubMed ID: 7391153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary concentrations and plasma protein binding of carbamazepine and carbamazepine 10,11-epoxide in epileptic patients.
    MacKichan JJ; Duffner PK; Cohen ME
    Br J Clin Pharmacol; 1981 Jul; 12(1):31-7. PubMed ID: 7248139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-performance liquid chromatographic determination of carbamazepine and carbamazepine 10,11-epoxide in plasma and saliva following solid-phase sample extraction.
    Hartley R; Lucock M; Cookman JR; Becker M; Smith IJ; Smithells RW; Forsythe WI
    J Chromatogr; 1986 Aug; 380(2):347-56. PubMed ID: 3760062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbamazepine 10,11-epoxide in children.
    Rylance GW; Edwards C; Gard PR
    Br J Clin Pharmacol; 1984 Dec; 18(6):935-9. PubMed ID: 6529533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of salivary drug monitoring for detecting efflux transporter overexpression.
    Fagiolino P; Vázquez M; Maldonado C; Ruiz ME; Volonté MG; Orozco-Suárez S; Lazarowski A
    Curr Pharm Des; 2013; 19(38):6701-8. PubMed ID: 23530513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fallacious results from measuring salivary carbamazepine concentrations.
    Dickinson RG; Hooper WD; King AR; Eadie MJ
    Ther Drug Monit; 1985; 7(1):41-5. PubMed ID: 3992621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-dose kinetics and metabolism of carbamazepine-10,11-epoxide.
    Tomson T; Tybring G; Bertilsson L
    Clin Pharmacol Ther; 1983 Jan; 33(1):58-65. PubMed ID: 6848300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daily variations in steady-state plasma concentrations of carbamazepine and its metabolites in epileptic children.
    Hartley R; Forsythe WI; McLain B; Ng PC; Lucock MD
    Clin Pharmacokinet; 1991 Mar; 20(3):237-46. PubMed ID: 2025982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-dose kinetics of an enteric-coated formulation of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine.
    Spina E; Tomson T; Svensson JO; Faigle JW; Bertilsson L
    Ther Drug Monit; 1988; 10(4):382-5. PubMed ID: 3201523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 24 hour variation of salivary carbamazepine and carbamazepine-10,11-epoxide concentrations in children with epilepsy.
    Bäckman E; Dahlström G; Eeg-Olofsson O; Bertler A
    Pediatr Neurol; 1987; 3(6):327-30. PubMed ID: 3149473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a monoclonal antibody-based immunochromatographic assay for the detection of carbamazepine and carbamazepine-10, 11-epoxide.
    Zhou S; Xu L; Liu L; Kuang H; Xu C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Mar; 1141():122036. PubMed ID: 32109745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbamazepine determination in saliva of children: enzyme immunoassay (EMIT) versus high pressure liquid chromatography.
    Paxton JW
    Epilepsia; 1982 Apr; 23(2):185-9. PubMed ID: 7042328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbamazepine metabolism in humans: effect of concurrent anticonvulsant therapy.
    Ramsay RE; McManus DQ; Guterman A; Briggle TV; Vazquez D; Perchalski R; Yost RA; Wong P
    Ther Drug Monit; 1990 May; 12(3):235-41. PubMed ID: 2112276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of carbamazepine and its active metabolite, carbamazepine-10,11-epoxide, in human plasma using high-performance liquid chromatography.
    Oh Ek; Ban E; Woo JS; Kim CK
    Anal Bioanal Chem; 2006 Nov; 386(6):1931-6. PubMed ID: 17019579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reanalysis of carbamazepine and carbamazepine-epoxide pharmacokinetics after multiple dosing of extended release formulation.
    Konsil J; Dechasathian S; Mason DH; Stevens RE
    J Pharm Pharm Sci; 2002; 5(2):169-75. PubMed ID: 12207869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic study of carbamazepine and its epoxide metabolite in humans.
    Sumi M; Watari N; Umezawa O; Kaneniwa N
    J Pharmacobiodyn; 1987 Nov; 10(11):652-61. PubMed ID: 3446773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative pharmacokinetic study of conventional and chewable carbamazepine in epileptic patients.
    Patsalos PN
    Br J Clin Pharmacol; 1990 May; 29(5):574-7. PubMed ID: 2350535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of carbamazepine and its 10,11-epoxide metabolite in children.
    Rane A; Höjer B; Wilson JT
    Clin Pharmacol Ther; 1976 Mar; 19(3):276-83. PubMed ID: 1261166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.